Dishman Carbogen Amcis

218.00
-2.01
(-0.91%)
Market Cap (₹ Cr.)
₹3,458
52 Week High
283.00
Book Value
₹359
52 Week Low
133.00
PE Ratio
PB Ratio
0.60
PE for Sector
37.21
PB for Sector
3.95
ROE
-0.51 %
ROCE
-0.03 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
8.33 %
Net Income Growth
-414.93 %
Cash Flow Change
44.37 %
ROE
-431.60 %
ROCE
-107.25 %
EBITDA Margin (Avg.)
-19.30 %

Financial Results

Quarterly Financials
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
144
96
151
108
166
98
154
116
173
132
162
131
197
141
201
143
165
38
64
79
91
81
100
90
96
109
127
91
128
84
98
100
108
115
117
Expenses
86
60
79
71
93
69
76
53
110
78
74
88
116
90
107
98
112
60
52
77
76
59
61
69
85
101
105
84
107
75
66
84
100
89
80
EBITDA
58
36
73
37
73
28
78
63
62
54
88
43
81
51
94
46
53
-22
12
3
15
22
39
21
11
8
22
7
21
9
33
16
8
26
37
Operating Profit %
37 %
28 %
30 %
28 %
18 %
26 %
38 %
31 %
26 %
31 %
32 %
23 %
34 %
27 %
33 %
5 %
26 %
-101 %
-70 %
-28 %
12 %
6 %
28 %
5 %
-0 %
3 %
1 %
-7 %
6 %
-7 %
-10 %
4 %
10 %
14 %
14 %
Depreciation
11
33
34
34
34
34
34
36
30
34
34
34
34
35
35
35
35
36
36
36
35
35
35
35
34
35
35
3
23
25
25
26
26
16
16
Interest
11
14
13
9
3
7
9
8
10
12
14
13
8
10
11
11
15
7
9
8
10
8
8
11
10
13
14
15
17
18
17
17
16
16
16
Profit Before Tax
36
-12
25
-5
36
-13
34
19
22
8
40
-5
39
5
49
-1
2
-65
-33
-41
-30
-21
-5
-26
-33
-40
-27
-10
-19
-33
-9
-27
-34
-6
5
Tax
13
0
3
1
6
0
4
3
1
1
9
-0
8
1
8
-0
0
0
0
0
18
0
0
0
-31
0
0
0
0
0
0
0
11
0
0
Net Profit
23
-7
14
-4
20
-8
22
12
11
5
25
-3
29
4
33
-2
5
-45
-18
-27
-142
-14
-3
-20
5
-25
-17
-7
-10
-21
-6
-18
-31
-3
14
EPS in ₹
2.87
-0.42
0.89
-0.22
1.25
-0.53
1.39
0.73
0.71
0.34
1.54
-0.19
1.79
0.22
2.02
-0.14
0.29
-2.88
-1.16
-1.72
-9.08
-0.89
-0.18
-1.25
0.31
-1.58
-1.10
-0.42
-0.65
-1.36
-0.37
-1.16
0.54
-0.22
0.91

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
12
5,537
5,807
5,816
5,735
5,552
5,214
5,181
5,077
Fixed Assets
0
1,927
1,853
1,715
1,633
1,510
1,356
1,382
1,416
Current Assets
12
770
753
736
765
723
766
650
587
Capital Work in Progress
0
41
48
70
89
121
118
143
74
Investments
0
2,761
2,937
2,907
2,900
2,882
3,032
2,913
2,848
Other Assets
12
808
969
1,124
1,113
1,039
708
743
739
Total Liabilities
12
766
1,016
924
939
877
983
1,067
1,024
Current Liabilities
3
401
521
526
620
531
551
642
619
Non Current Liabilities
9
365
495
398
318
346
431
425
405
Total Equity
0
4,771
4,792
4,892
4,796
4,675
4,232
4,114
4,053
Reserve & Surplus
0
4,771
4,759
4,860
4,764
4,643
4,200
4,083
4,021
Share Capital
0
0
32
32
31
31
31
31
31

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
1
29
-12
10
-2
-10
9
-11
-10
Investing Activities
0
0
-16
-175
-24
-74
62
-173
41
97
Operating Activities
-1
3
270
20
120
197
-2
227
-53
24
Financing Activities
1
-2
-225
142
-85
-124
-71
-46
1
-131

Share Holding

% Holding
Apr 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
63.17 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
FIIs
9.83 %
6.38 %
5.91 %
4.40 %
4.60 %
5.50 %
5.85 %
6.20 %
7.20 %
9.34 %
8.90 %
8.80 %
8.61 %
8.70 %
8.04 %
8.17 %
DIIs
13.57 %
8.94 %
6.75 %
6.15 %
6.31 %
6.91 %
6.63 %
4.28 %
3.87 %
2.56 %
3.14 %
3.52 %
3.69 %
2.37 %
1.47 %
1.23 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.42 %
25.36 %
28.01 %
30.13 %
29.77 %
28.26 %
28.19 %
30.20 %
29.61 %
28.78 %
28.64 %
28.36 %
28.39 %
29.61 %
31.16 %
31.28 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,765.00 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
1,457.80 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
2,532.25 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
1,193.90 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
940.60 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
2,038.35 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
1,220.50 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
5,560.00 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
1,463.10 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
1,567.45 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
63.54
ATR(14)
Volatile
12.66
STOCH(9,6)
Neutral
60.28
STOCH RSI(14)
Overbought
93.31
MACD(12,26)
Bullish
4.03
ADX(14)
Weak Trend
15.53
UO(9)
Bearish
54.24
ROC(12)
Uptrend But Slowing Down
16.12
WillR(14)
Neutral
-24.30